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A STUDY ON THE SEXUAL DYSFUNCTION OF FEMALE RECIPIENTS WHO
UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION
Kim, J.W., Kim, K.S., Bok, J.N., Lee, S.Y. The Catholic University of
Korea, Seoul, Korea
Background/ Aims: Many studies have shown sexual dysfunction
in recipients who underwent HSCT, particularly for female recipi-
ents. However, there were no studies for sexual dysfunction of female
recipients who underwent HSCT in Korea, because the sexual prob-
lem was just considered very private. The purposes of this study was
to analysis the level of sexual dysfunction of female recipients who
underwent HSCT and provide basic data contributed in taking
care of female recipients having sexual problems after HSCT.
Methods: The sexual function of 60 female recipients who have
been visiting hospital after HSCT, were selected from database of
Catholic HSCT center, St. Mary’s Hospital; was assessed using the
Korean translated version of FSFI (female sexual function index)
questionnaire.
Results: More than 80% of female recipients had hematological
malignancies; more than 76.7 % were allograft recipients. Gonadal
disturbances were present in 51.7 % of female recipients. 22.5 %
of them were receiving estrogen replacement and only 23.3% had
regular menses. 61.7 % of them had never done sexual activity in
the past four weeks from the assessment date. The reason why they
didn’t have sexual activity was associate with the uninteresting of
themselves (48.3%), the fear of infection (44.9%) and the uninterest-
ing of their sexual partner (13.8%). More than 94% of female recip-
ients were found to have low level of FSFI total score as sexual
dysfunction. They were found to have each domain scores on sexual
desire, arousal, lubrication, orgasm and satisfaction as sexual dys-
function; 80.8%, 98.1%, 92.3%, 86.5%, 84.6% and 86.5%
of them respectively. These results showed significant sexual
dysfunction of female recipients who underwent HSCT.
Conclusion: The Sexual dysfunction of female recipients, who
underwent Hematopoietic Stem Cell Transplantation, is usual after
HSCT. We suggest stressing the importance of intervention for fe-
male recipients having sexual problems and there are needed to apply
hormonal, mechanical, and behavioral methods to prevent sexual
dysfunction in further studies.145
SUICIDE IN ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTA-
TION (HSCT) PATIENTS, IS IT A PROBLEM?
Larsen, H.B.1, Petersen, H.1, Roepstorff, C.1, Sengelow, H.1,
Heilmann, C.2 1Rigshospitalet, Copenhagen, Denmark; 2Rigshospitalet,
Copenhagen, Denmark
Introduction: A review of the literature showed that the prob-
lem of suicide and suicide attempts among HSCT patients has
only been examined in two studies from the 1990´ties.
Since suicide continues to be a problem in HSCT patients we
wanted to examine the problem in a Danish population based
context.
Patients andmethods:Follow-up data from the Danish cohort of
HSCT patients (N: 1217 September 1. 2008) revealed that three pa-
tients had committed suicide, and that at least three patients had
attempted to do so.Results: The three patients who committed suicide were all
males, two of them were severely ill, one with a prolonged inpatient
period due to transplantation complications and one had recently
been diagnosed with relapse following HSCT. The last patient
was 10 years from HSCT and suffered from depression. Whether,
in the Danish cohort, other patients have committed suicide may be
a matter of definition e.g. a patient, who refused to take his medi-
cine, because he did not wish to live, die three months later due
to GvHD. The three patients whom we know attempted suicide
are all females, and their attempts occurred approximately 10 years
after HSCT, during childhood or adolescence. One patient has se-
vere extensive long-term complications following HSCT and the
other two patients have been complaining of depressive thoughts.
Whether other patients have attempted suicide is unknown, but it
is likely that our follow-up data collection does not always pick
up such events.
Conclusion: Suicide and suicide attempts are not well described
in the HSCT literature. It’s unknown whether we actually capture
all suicides and suicide attempts in our medical records and by our
data collection procedures. It’s also unknown what the incidence
of suicide is following treatment with HSCT. We would therefore
suggest a multicenter/registry analysis of the problem. In order to
capture information regarding HSCT patients that commit suicide
we need to know their age, gender, time after HSCT, complications
(e.g. GvH, infection) and psychological profile. This would provide
us with further knowledge and understanding of the problem, and
hopefully help us care better for patients at risk for post transplanta-
tion suicide.146
PANCREATIC ATROPHY IS ASSOCIATED WITH GASTROINTESTINAL
CHRONIC GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC
PERIPHERAL BLOOD STEM CELL TRANSPLANTATION
Nakasone, H.1,2, Ito, A.1, Endo, H.1, Muramatsu-Kida, M.1, Izutsu, K.1,
Usuki, K.1 1Kanto Medical Center, NTT, EC; 2Saitama Medical Center,
Jichi Medical University Graduate School
The weight loss and malnutrition commonly observed in patients
following hematopoietic stem cell transplantation is due to pancre-
atic insufficiency, at least in part. To date, few reports have evaluated
pancreatic morphology in the chronic phase of transplantation. We
evaluated pancreatic atrophy following allogeneic peripheral blood
stem cell transplantation (PBSCT) by retrospectively reviewing pa-
tients with chronic graft-versus-host disease (cGVHD) following
PBSCT from related donors. The study was carried out at our insti-
tution between June 2001 and October 2007. Computed tomogra-
phy (CT) scans were available for pre- and post-transplantation
pancreatic assessment from 25 of 26 patients with cGVHD who
had survived at least 100 days. The median patient age was 60 years.
Sixteen patients received fludarabine-based reduced-intensity condi-
tioning regimens. The median duration of observation for survivors
was 4.1 years. Pancreatic atrophy was observed in five (20%) of 25
patients, while steatorrhea was documented in only one (5%). Uni-
variable analysis revealed that pancreatic atrophy was significantly
associated with involvement of liver (P5 0.041) and gastrointestinal
(GI) tract (P 5 0.022) of cGVHD, while multivariable analysis
showed that only GI cGVHD was a significantly associated factor
[OR: 16.0 (95%CI: 1.1–364), P 5 0.043]. Overall survival (OS) be-
tween patients with and without pancreatic atrophy was similar
(40.0% and 56.3%, respectively; P 5 0.98). Morphological assess-
ment by CT detected pancreatic abnormalities more sensitively, eas-
ily, and less invasively than assessment via steatorrhea observation or
biopsy. Pancreatic atrophy is not a rare complication of PBSCT in
patients with cGVHD, particularly in those with GI cGVHD.147
PSYCHOSOCIAL FACTORS AND OVERALL SURVIVAL AFTER AUTOLOGOUS
AND ALLOGENEIC BMT
Hahn, T.1, Jensen, S.1, Lopez, F.1, Zevon, M.1, Tan, W.2, Wilding, G.2,
Paddon, C.1, White, J.1, Thomas, J.1, Battiwalla, M.1, Smiley, S.L.1,
McCarthy, P.L.1 1Roswell Park Cancer Institute, Buffalo, NY; 2Roswell
Park Cancer Institute, Buffalo, NY
Various psychosocial factors have been assessed in BMT patients
(pts), but there are few reports of a comprehensive psychosocial
